
ESMO 2017: Patients with High Risk Prostate Cancer May Benefit “Equally” From Two New Treatments
Patients with high risk prostate cancer starting long-term hormone therapy may benefit from two new…
Patients with high risk prostate cancer starting long-term hormone therapy may benefit from two new…
Johns Hopkins Kimmel Cancer Center scientists report data from a new study providing evidence that…
A new test has been developed to make the vital distinction between aggressive and less…
Researchers have developed the first computer machine-learning model to accurately predict which patients diagnosed with…
By Allison Linn. How Microsoft computer scientists and researchers are working to “solve” cancer At Microsoft’s…
A diagnosis of high cholesterol is associated with reduced mortality and improved survival in the…